Lakefront Biotherapeutics NV LKFT
Set alert
32.02 USD -0.26 -0.81%
At close
32.18 +0.16 +0.50%
Pre-market · Nov 3, 8:46 AM ET
31.90 Day range 32.50
25.68 52-week range 36.24
- YTD
- -2.08%
- 1 year
- +0.76%
- Open
- 32.44
- Prev close
- 32.28
- Mkt cap
- 2.11B
- Vol
- 259.07K
- Avg vol
- 286.47K
- EPS
- 10.52
- P/E
- 3.04
- Div yield
- 0.00%
More statistics
- Low
- 31.90
- High
- 32.50
- Forward P/E
- -26.89
- Beta
- 0.02
- Short ratio
- 3.95
- Inst. own
- 23.68%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 29.49
- 200-d avg
- 29.92
- 1y target
- 30.41
Analyst view
Consensus: hold
Hold
Price target (mean) 30.41 -5.0% downside
Now 32.02
- Target (low)
- 21.27
- Target (mean)
- 30.41
- Target (high)
- 44.02
Ratings (0m) 6 2 buy · 3 hold · 1 sell
- Strong buy1
- Buy1
- Hold3
- Sell1
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.23 | 0.23 – 0.23 | -0.178 | +229.2% | 41.18M | -42.1% | 1 |
| Next quarter | -0.165 | -0.54 – 0.21 | 12.27 | -101.3% | 106.78M | -88.1% | 2 |
| Current year | -0.71 | -0.71 – -0.71 | 10.21 | -107.0% | 117.22M | -89.5% | 1 |
| Next year | -1.06 | -1.75 – -0.37 | -0.71 | -49.3% | 84.62M | -27.8% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 23, 2026 | RBC Capital | Upgrade | Sector Perform | Outperform |
| Aug 11, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 11, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Feb 25, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |